Cargando…

Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model

Glioblastoma is an aggressive brain tumour found in adults, and the therapeutic approaches available have not significantly increased patient survival. Recently, we discovered that ELTD1, an angiogenic biomarker, is highly expressed in human gliomas. Polyclonal anti‐ELTD1 treatments were effective i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zalles, Michelle, Smith, Nataliya, Ziegler, Jadith, Saunders, Debra, Remerowski, Shannon, Thomas, Lincy, Gulej, Rafal, Mamedova, Nadya, Lerner, Megan, Fung, Kar‐Ming, Chung, Junho, Hwang, Kyusang, Jin, Junyeong, Wiley, Graham, Brown, Chase, Battiste, James, Wren, Jonathan D., Towner, Rheal A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991683/ https://www.ncbi.nlm.nih.gov/pubmed/31863639 http://dx.doi.org/10.1111/jcmm.14867

Ejemplares similares

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
por: Zalles, Michelle, et al.
Publicado: (2020)

ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
por: Zalles, Michelle, et al.
Publicado: (2021)

A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007
por: Zalles, Michelle, et al.
Publicado: (2021)

OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
por: Thomas, Lincy, et al.
Publicado: (2020)

OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()
por: Towner, Rheal A., et al.
Publicado: (2018)

XRN2 Is Required for Cell Motility and Invasion in Glioblastomas
por: Dang, Tuyen T., et al.
Publicado: (2022)

AG488 as a therapy against gliomas
por: Ziegler, Jadith, et al.
Publicado: (2017)

Novel approaches to combat chemoresistance against glioblastomas
por: Towner, Rheal A., et al.
Publicado: (2020)

In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis
por: Smith, Nataliya, et al.
Publicado: (2020)

OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera
por: Towner, Rheal A., et al.
Publicado: (2022)

ELTD1—An Emerging Silent Actor in Cancer Drama Play
por: Sevastre, Ani-Simona, et al.
Publicado: (2021)

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent
por: Kan, Anna, et al.
Publicado: (2018)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer
por: Sun, Jiawei, et al.
Publicado: (2021)

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype
por: Sheldon, Helen, et al.
Publicado: (2021)

MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies
por: Towner, Rheal A., et al.
Publicado: (2021)

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
por: Niinivirta, Marjut, et al.
Publicado: (2020)

Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion
por: Guihurt Santiago, Jonathan, et al.
Publicado: (2021)

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma
por: Huang, Hua, et al.
Publicado: (2021)

Physical Forces in Glioblastoma Migration: A Systematic Review
por: Grossen, Audrey, et al.
Publicado: (2022)

Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
por: Dissanayake, Ranga, et al.
Publicado: (2023)

Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts
por: Coutinho de Souza, Patricia, et al.
Publicado: (2015)

Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas
por: He, Ting, et al.
Publicado: (2011)

A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
por: Towner, Rheal A., et al.
Publicado: (2015)

Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy
por: Ahn, Bumsoo, et al.
Publicado: (2019)

ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis
por: Li, Junjun, et al.
Publicado: (2019)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
por: Masiero, Massimo, et al.
Publicado: (2013)

Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4)
por: Lu, Shun, et al.
Publicado: (2017)

ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile
por: Favara, David M., et al.
Publicado: (2019)

ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial–Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK
por: Sun, Bo, et al.
Publicado: (2021)

Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling
por: Favara, David M., et al.
Publicado: (2021)

Feasibility Evaluation of Detecting Hydroxymethylphosphine Oxide In Vivo by (31)P-MRS
por: Doblas, Sabrina, et al.
Publicado: (2010)

Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features
por: Rios Velazquez, Emmanuel, et al.
Publicado: (2015)

Differentiation of Human GBM From Non-GBM Brain Tissue With Polarization Imaging Technique
por: Liu, Yi-Rong, et al.
Publicado: (2022)

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
por: Mukherjee, Sumit, et al.
Publicado: (2018)

Advances in nanotechnology for the treatment of GBM
por: Wei, Dongyan, et al.
Publicado: (2023)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants
por: Favara, David M., et al.
Publicado: (2019)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
por: Binder, Zev A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_urlpbipeb4v14v7la27ip8kok5